A potential epigenetic marker mediating serum folate and vitamin Blevels contributes to the risk of ischemic stroke

Loo Keat Wei, Heidi Sutherland, Anthony Au, Emily Camilleri, Larisa M. Haupt, Siew Hua Gan, Lyn R. Griffiths

Research output: Contribution to journalArticlepeer-review

31 Scopus citations

Abstract

Stroke is a multifactorial disease that may be associated with aberrant DNA methylation profiles. We investigated epigenetic dysregulation for the methylenetetrahydrofolate reductase (MTHFR) gene among ischemic stroke patients. Cases and controls were recruited after obtaining signed written informed consents following a screening process against the inclusion/exclusion criteria. Serum vitamin profiles (folate, vitamin B and homocysteine) were determined using immunoassays. Methylation profiles for CpGs A and B in the MTHFR gene were determined using a bisulfite-pyrosequencing method. Methylation of MTHFR significantly increased the susceptibility risk for ischemic stroke. In particular, CpG A outperformed CpG B in mediating serum folate and vitamin Blevels to increase ischemic stroke susceptibility risks by 4.73-fold. However, both CpGs A and B were not associated with serum homocysteine levels or ischemic stroke severity. CpG A is a potential epigenetic marker in mediating serum folate and vitamin Bto contribute to ischemic stroke.

Original languageEnglish (US)
Article number167976
JournalBioMed Research International
Volume2015
DOIs
StatePublished - 2015

Fingerprint Dive into the research topics of 'A potential epigenetic marker mediating serum folate and vitamin Blevels contributes to the risk of ischemic stroke'. Together they form a unique fingerprint.

Cite this